Latest News and Press Releases

PHILADELPHIA, June 24, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that the United States District Court for the Eastern District of Pennsylvania has approved the following announcement of a...

NEW YORK, June 23, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Abbott Laboratories (“Abbott” or the “Company”) (NYSE: ABT). Such investors are advised to...

NEW YORK, June 23, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Enochian Biosciences, Inc. (“Enochian” or the “Company”) (NASDAQ: ENOB).   Such investors...

NEW YORK, June 23, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Unity Software, Inc. (“Unity” or the “Company”) (NASDAQ: U). Such investors are advised to...

NEW YORK, June 23, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Wells Fargo & Company (“Wells Fargo” or the “Company”) (NYSE: WFC).   Such investors...

NEW YORK, June 23, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Novartis AG (“Novartis” or the “Company”) (NYSE: NVS).   Such investors are advised to...

NEW YORK, June 23, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of TG Therapeutics, Inc. (“TG Therapeutics” or the “Company”) (NASDAQ: TGTX). Such investors...

NEW YORK, June 23, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Blueprint Medicines Corporation (“Blueprint” or the “Company”) (NASDAQ: BPMC).   Such...

NEW YORK, June 23, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Centessa Pharmaceuticals plc (“Centessa” or the “Company”) (NASDAQ: CNTA).   Such...

NEW YORK, June 23, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Lightwave Logic, Inc. (“Lightwave” or the “Company”) (NASDAQ: LWLG).   Such investors are...